| Date Filed | Type | Description |
| 08/10/2023 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 98,750 shares
@ $0 |
|
| 12/14/2022 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 3,820 shares
@ $1.98, valued at
$7.6k
Sold 6,253 shares
@ $1.96, valued at
$12.3k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2022 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 101,250 shares
@ $0 |
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 9,045 shares
@ $6.95, valued at
$62.9k
Sold 12,855 shares
@ $6.71, valued at
$86.3k
|
|
| 11/16/2020 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Sold 15,000 shares
@ $5.93, valued at
$89k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 4,401 shares
@ $3.1, valued at
$13.6k
|
|
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 3,733 shares
@ $6.76, valued at
$25.2k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2018 |
4
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 5,700 shares
@ $12.7, valued at
$72.4k
|
|
| 04/05/2018 |
4
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 14,250 shares
@ $0 |
|
| 02/16/2018 |
4
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 29,250 shares
@ $0 |
|
| 02/07/2018 |
4
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 3,333 shares
@ $14.22, valued at
$47.4k
Sold 11,000 shares
@ $13.77, valued at
$151.5k
|
|
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2016 |
3/A
| Woodrow Adam (VP & Chief Commercial Officer) has filed a Form 3/A on Paratek Pharmaceuticals, Inc. |